In melanoma, where RICTOR amplification and overexpression are frequent, down-regulation of RICTOR with shRNA severely impaired the formation of vasculogenic mimicry (VM) via the AKT-MMP-2/9 pathway. Here, AKT1 is linked to melanoma.